Axil Brands, Inc. (AXIL) stock
AXILNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 6, 2026Score 19/3059% below fair value
$4.81−0.13 (-2.63%)
Close on Nov 18, 2026Market cap $32.82MP/E 14.1Yield –
Axil Brands revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Axil Brands's revenue for the twelve months ending Aug 31, 2026 was $30.08M, up 10.3% year over year. For fiscal 2026 it was $30.85M, up 17.5% from the year before. The highest annual figure on record is $30.85M in fiscal 2026.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | May 31, 2026 | $30.85M | +17.5% |
| FY2025 | May 31, 2025 | $26.26M | -4.5% |
| FY2024 | May 31, 2024 | $27.50M | +16.9% |
| FY2023 | May 31, 2023 | $23.52M | +906.8% |
| FY2022 | May 31, 2022 | $2.34M | +43.0% |
| FY2021 | May 31, 2021 | $1.63M | +61.3% |
| FY2020 | May 31, 2020 | $1.01M | +2.0% |
| FY2019 | May 31, 2019 | $992.67K | +6.4% |
| FY2018 | May 31, 2018 | $933.22K | +60.3% |
| FY2017 | May 31, 2017 | $582.01K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Aug 31, 2026 | $6.09M | -11.2% |
| Q4 FY2026CQ2 2026 | May 31, 2026 | $8.56M | +48.9% |
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | $7.29M | +5.4% |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | $8.13M | +5.2% |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | $6.86M | +17.2% |
| Q4 FY2025CQ2 2025 | May 31, 2025 | $5.75M | -11.5% |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | $6.92M | +7.0% |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | $7.73M | -8.2% |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | $5.85M | -4.2% |
| Q4 FY2024CQ2 2024 | May 31, 2024 | $6.50M | -62.7% |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | $6.47M | +14.4% |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | $8.42M | +25.1% |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | $6.11M | +44.1% |
| Q4 FY2023CQ2 2023 | May 31, 2023 | $17.41M | +3205.9% |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | $5.66M | +1087.4% |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | $6.73M | +1263.3% |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | $4.24M | +404.9% |
| Q4 FY2022CQ2 2022 | May 31, 2022 | $526.79K | +47.9% |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | $476.38K | +30.5% |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | $493.82K | -23.3% |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | $839.27K | +212.6% |
| Q4 FY2021CQ2 2021 | May 31, 2021 | $356.13K | -11.1% |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | $364.97K | +131.2% |
| Q2 FY2021CQ4 2020 | Nov 30, 2020 | $644.06K | +96.0% |
| Q1 FY2021CQ3 2020 | Aug 31, 2020 | $268.45K | +113.6% |
| Q4 FY2020CQ2 2020 | May 31, 2020 | $400.60K | +21.3% |
| Q3 FY2020CQ1 2020 | Feb 29, 2020 | $157.88K | -43.8% |
| Q2 FY2020CQ4 2019 | Nov 30, 2019 | $328.55K | +36.8% |
| Q1 FY2020CQ3 2019 | Aug 31, 2019 | $125.68K | -11.0% |
| Q4 FY2019CQ2 2019 | May 31, 2019 | $330.27K | -29.2% |
| Q3 FY2019CQ1 2019 | Feb 28, 2019 | $281.06K | +28.2% |
| Q2 FY2019CQ4 2018 | Nov 30, 2018 | $240.16K | +76.7% |
| Q1 FY2019CQ3 2018 | Aug 31, 2018 | $141.18K | +26.9% |
| Q4 FY2018CQ2 2018 | May 31, 2018 | $466.81K | +295.8% |
| Q3 FY2018CQ1 2018 | Feb 28, 2018 | $219.25K | +39.1% |
| Q2 FY2018CQ4 2017 | Nov 30, 2017 | $135.91K | -3.2% |
| Q1 FY2018CQ3 2017 | Aug 31, 2017 | $111.25K | – |
| Q4 FY2017CQ2 2017 | May 31, 2017 | $117.94K | – |
| Q3 FY2017CQ1 2017 | Feb 28, 2017 | $157.59K | – |
| Q2 FY2017CQ4 2016 | Nov 30, 2016 | $140.34K | – |
See a number that looks wrong?